SAB Biotherapeutics Inc (SABS)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |||||
| Total Revenue | 2.16M | 581k | 86k | 1.27M | 305k | 945k | 263k | 0 |
| Operating Income | -7.86M | -7.4M | -6.48M | -5.32M | -18.87M | -11.39M | -10.2M | -11.31M |
| Pre Tax Income | -7.85M | -7.35M | -6.88M | -5.1M | -22.86M | -5.03M | -7.34M | -10.35M |
| Net Income | -7.88M | -7.35M | -6.88M | -5.1M | -22.86M | -5.03M | -7.34M | -10.35M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | -7.83M | -7.4M | -6.48M | -5.23M | -18.54M | -10.92M | -9.83M | -10.56M |
| EBITDA | -6.96M | -6.51M | -5.61M | -4.36M | -17.95M | -9.43M | -9.17M | -10.36M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 60.88M | 23.9M | 2.24M |
| Operating Income | -9k | -13.39M | -28.92M | -38.08M |
| Pre Tax Income | -9k | -17.15M | -18.72M | -42.19M |
| Net Income | -9k | -17.15M | -18.74M | -42.19M |
| Preferred Dividends | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | -0.003 | -0.394 | -0.436 | -0.806 |
| EBIT | -9k | -13.39M | -28.88M | -37.64M |
| EBITDA | -9k | -11.91M | -25.75M | -34.42M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
